Columbia University Irving Cancer Center

New York, New York 10032

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer

Studies at this site

• Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer — Recruiting now
• ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC — Running, not enrolling